tiprankstipranks
Trending News
More News >
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
US Market

Madrigal Pharmaceuticals (MDGL) Ownership - Who Owns Madrigal Pharmaceuticals?

Compare
1,231 Followers

Madrigal Pharmaceuticals (MDGL) Ownership Overview

19.56%25.96%0.25%14.11%40.11%
19.56% Insiders
0.25% Other Institutional Investors
14.11% ETFs
40.11% Public Companies and
Individual Investors
The ownership structure of Madrigal Pharmaceuticals (MDGL) stock is a mix of institutional, retail, and individual investors. Approximately 40.33% of the company’s stock is owned by Institutional Investors, 19.56% is owned by Insiders, and 40.11% is owned by Public Companies and Individual Investors.
The ownership structure of Madrigal Pharmaceuticals (MDGL) stock is a mix of institutional, retail, and individual investors. Approximately 26.21% of the company’s stock is owned by Institutional Investors, 19.56% is owned by Insiders, and 14.11% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 14, 2025
xxxxxxxxxxxxx
$5082372
Mar 07, 2025
xxxxxxxxxxxxx
$4817012
Mar 05, 2025
xxxxxxxxxxxxx
$386831
Mar 04, 2025
xxxxxxxxxxxxx
$418480

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$203347
Mar 31, 2025
xxxxxxxxxxxxx
$11160359
Mar 31, 2025
xxxxxxxxxxxxx
$95384232

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,042,000Institution9.25%655,686,200
1,974,590Institution8.94%634,040,849
1,794,831Insider8.13%576,320,234
1,620,618Institution7.34%520,380,440
1,467,879Institution6.65%471,335,947
1,422,141Institution6.44%456,649,475
1,116,584Insider5.06%358,535,122
841,989Insider3.81%270,362,668
828,840Institution3.75%266,140,524
414,235Institution1.88%133,010,859

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,467,879Institution6.65%471,335,947
1,422,141Institution6.44%456,649,475
291,874Institution1.32%93,720,741
197,639Institution0.90%63,461,883
193,216Institution0.88%62,041,658
191,301Institution0.87%61,426,751
153,039Institution0.69%49,140,823
137,884Institution0.62%44,274,552
135,295Institution0.61%43,443,225
123,441Institution0.56%39,636,905

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
517,042Institution2.34%176,450,923
458,114Institution2.07%147,100,405
416,579Institution1.89%128,543,782
373,596Institution1.69%120,417,463
275,186Institution1.25%93,912,726
259,284Institution1.17%88,485,851
161,613Institution0.73%51,893,934
120,034Institution0.54%38,542,917
82,316Institution0.37%28,091,981
80,620Institution0.37%25,985,438

FAQ

Who Owns Madrigal Pharmaceuticals Inc (MDGL)?
According to the latest TipRanks data, approximately 0.25% of the company's stock is held by institutional investors, 19.56% is held by insiders, and 40.11% is held by retail investors.
    What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.25% of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors.
      What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 40.11% of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors.
        Who owns the most shares of Madrigal Pharmaceuticals Inc (MDGL)?
        John Paulson owns the most shares of Madrigal Pharmaceuticals Inc (MDGL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis